Skip to main content

Covid-19: Four more events postponed

3rd July 2020

Submitted by:

Andrew Warmington

At the end of June, three more major exhibitions that attract high attendances from the fine and speciality chemicals and which were due to take place in the autumn, were cancelled or postponed to 2021 due to the Covid-19 pandemic: CPhI Worldwide, In-Cosmetics, ChemUK and Making Pharmaceuticals. This leaves only Chemspec Europe among the major events still going ahead, as things stand.

Organiser UBM has cancelled the CPhI Worldwide that was due to take place in Milan on 13-15 October. They said that they were confident of being able to deliver a safe and secure event, but that, “with other countries and locations at different stages of recovery from COVID-19 and with international travel only returning gradually”, it would have been difficult to ensure the usual “level of participation and high-quality, in-person experience”. I

n its place, UBM is launching the ‘Festival of Pharma’, which will run on 5-16 October. This is described as the “world’s largest pharmaceutical virtual meeting”, combining an online expo with presentations and networking opportunities. Over 20,000 attendees from over 700 companies are expected to participate.

Likewise, Reed Exhibitions has postponed In-Cosmetics Global for the third time. The next show will take place, still in Barcelona as envisaged for this year, on 13-15 April 2021. As with CPhI Worldwide, there will be a virtual event on dates to be confirmed in October .

Over 80% of In-Cosmetics Global attendees are international from countries at different stages of the global pandemic and with varying government advice and travel restrictions, so we concluded 2020 is not a viable time to hold a live event in Europe,” Reed said. In-Cosmetics Latin America and North America will also not take place this year for the same reasons. However, with business recovery in the region and the ongoing discussions to re-open borders for business travel, there are as yet no plans to change the dates of In-Cosmetics Asia in Bangkok on 3-5 November.

Despite the show being UK-specific, ChemUK 2020 has also been postponed due to the “continued uncertainties regarding Covid-19 disruption to individuals, organisations and businesses”. It will return on 12-13 May 2021 at the new venue of the NEC in Birmingham, thus allowing it to expand to 300+ exhibitors and 120+ speakers, the organisers, UK Industry Events, said.

Similarly, the small-stand Making Pharmaceuticals event has been put back from 26-27 October to 6-7 July 2021, still at the Ricoh Arena in Coventry, UK. The organisers said that “organising an event with two-metre social distancing measures whilst feasible, is impractical”, because it restricts the layout, access and flow of attendees, thus diminishing the value of a face-to-face event.

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it.

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington